Clinical trial
Effect of BTL-899 Device for Non-invasive Lipolysis on Human Flanks
NCT05260164 is registered in ClinicalTrials.gov with BTL Industries Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of BTL-899 Device for Non-invasive Lipolysis on Human Flanks
- Lead sponsor
- BTL Industries Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 11, 2022
- Completion date
- January 30, 2023
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fat burn